Document is current
Any future updates will be listed below
-
Authors
Ohara, Chisato
Sekiguchi, Atsushi
Takakura, Shu
Endo, Yuka
Tamura, Naho
Kikuchi, Hiroe
Maruo, Kazushi
Sugawara, Norio
Hatano, Kenji
Kawanishi, Hitomi
Funaba, Misako
Sugawara, Ayako
Nohara, Nobuhiro
Kawai, Keisuke
Fukudo, Shin
Sudo, Nobuyuki
Cooper, Zafra
Yoshiuchi, Kazuhiro
Ando, Tetsuya http://orcid.org/0000-0003-2643-6067
-
Funding
Funding for this research was provided by:
Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP (29-2)
Health and Labour Sciences Research Grants for research on intractable diseases from Ministry of Health, Labour and Welfare of Japan (H29-Nanbyou-Ippan-059)
Mitsubishi Foundation (H30-Shakai-Fukushi 1)
Japan Agency for Medical Research and Development (19dm0307104h0001)
- License Information
-
More Information
Article History
Received: 7 June 2019
Accepted: 3 February 2020
First Online: 24 February 2020
Ethics approval and consent to participate
: Ethics approval was granted by the Institutional Review Board of the NCNP in Tokyo, Japan (November 24, 2017; A2017–069). All participants will be informed about the purpose and design of the trial, its risks and benefits, and their rights and obligations. Signed informed consent will be obtained from all participants before enrolment.
: Consent for publication was included in the consent to participate form.
: The authors declare that they have no competing interests.
